vindesine has been researched along with Astrocytoma, Grade IV in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, T; Ghoda, M; Hori, S; Mori, T; Morikawa, N; Takeyama, M | 1 |
Bruner, JM; Chang, SM; Choucair, A; Flynn, PJ; Gleason, MJ; Hess, KR; Jaeckle, KA; Kyritsis, AP; Levin, VA; Prados, MD; Uhm, JH | 1 |
1 trial(s) available for vindesine and Astrocytoma, Grade IV
Article | Year |
---|---|
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Eflornithine; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Procarbazine; Prospective Studies; Time Factors; Vincristine; Vindesine | 2000 |
1 other study(ies) available for vindesine and Astrocytoma, Grade IV
Article | Year |
---|---|
Pharmacokinetics of methotrexate in plasma and cerebrospinal fluid.
Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Blood-Brain Barrier; Female; Fluorescence Polarization Immunoassay; Glioblastoma; Humans; Infusions, Intra-Arterial; Methotrexate; Middle Aged; Peplomycin; Ventriculoperitoneal Shunt; Vindesine | 1997 |